Skip Navigation


Annals of Oncology Advance Access originally published online on January 12, 2006
Annals of Oncology 2006 17(7):1173-1174; doi:10.1093/annonc/mdj124
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/7/1173-a    most recent
mdj124v2
mdj124v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aschele, C.
Right arrow Articles by Pucciarelli, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Aschele, C.
Right arrow Articles by Pucciarelli, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society for Medical Oncology

letter to the editor

Reply to Letter to the Editor ‘Weekly oxaliplatin and pre-operative radiotherapy as a new neoadjuvant therapy for locally advanced rectal cancer’, by T. Watanabe et al. (Ann Oncol 2006; 17: 1173)

The first 10% of the full text of this article appears below.

The letter by Watanabe et al. regarding the report of our phase I–II study of weekly oxaliplatin and infused 5-fluorouracil combined with standard pre-operative radiotherapy for locally advanced rectal cancer, published in the July 2005 issue of Annals of Oncology [1Go], gives us the opportunity to define more clearly the surgical complications of this regimen. In summary, data on post-operative morbidity have been requested, concern has been raised on . . . [Full Text of this Article]

C. Aschele1,*, M. L. Friso2, P. Del Bianco3 and S. Pucciarelli4

1 Department of Medical Oncology and Cancer Prevention, E. O. Ospedali Galliera, Genova; 2 Department of Radiotherapy, Padova University Hospital, Padova; 3 Clinical Epidemiology Unit, Regional Cancer Centre, Padova; 4 Clinica Chirurgica II, Padova University Hospital, Padova, Italy

* (E-mail: carlo.aschele@galliera.it)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?